|Genetic differences in cytochrome P450 enzymes and antidepressant treatment response|
K Hodgson, K Tansey, MZ Dernovšek, J Hauser, N Henigsberg, W Maier, ...
Journal of psychopharmacology 28 (2), 133-141, 2014
|Functional polymorphism in the brain‐derived neurotrophic factor gene interacts with stressful life events but not childhood maltreatment in the etiology of depression|
GW Brown, TKJ Craig, TO Harris, J Herbert, K Hodgson, KE Tansey, ...
Depression and anxiety 31 (4), 326-334, 2014
|Approach–avoidance processes contribute to dissociable impacts of risk and loss on choice|
ND Wright, M Symmonds, K Hodgson, THB Fitzgerald, B Crawford, ...
Journal of Neuroscience 32 (20), 7009-7020, 2012
|Shared genetic factors influence head motion during MRI and body mass index|
K Hodgson, RA Poldrack, JE Curran, EE Knowles, S Mathias, ...
Cerebral Cortex 27 (12), 5539-5546, 2016
|Genetic predictors of antidepressant side effects: A grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study|
K Hodgson, R Uher, AA Crawford, G Lewis, MC O’Donovan, R Keers, ...
Journal of psychopharmacology 28 (2), 142-150, 2014
|Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables|
R Iniesta, K Hodgson, D Stahl, K Malki, W Maier, M Rietschel, O Mors, ...
Scientific reports 8 (1), 5530, 2018
|Exploring the role of drug-metabolising enzymes in antidepressant side effects|
K Hodgson, KE Tansey, R Uher, MZ Dernovšek, O Mors, J Hauser, ...
Psychopharmacology 232 (14), 2609-2617, 2015
|Human responses to unfairness with primary rewards and their biological limits|
ND Wright, K Hodgson, SM Fleming, M Symmonds, M Guitart-Masip, ...
Scientific reports 2, 593, 2012
|The genetic basis of depression|
K Hodgson, P McGuffin
Behavioral Neurobiology of Depression and Its Treatment, 81-99, 2012
|Epigenetic age acceleration assessed with human white-matter images|
K Hodgson, MA Carless, H Kulkarni, JE Curran, E Sprooten, EE Knowles, ...
Journal of Neuroscience, 0177-17, 2017
|The genetic basis of the comorbidity between cannabis use and major depression|
K Hodgson, L Almasy, EEM Knowles, JW Kent Jr, JE Curran, TD Dyer, ...
Addiction 112 (1), 113-123, 2017
|Genome-wide significant loci for addiction and anxiety|
K Hodgson, L Almasy, EEM Knowles, JW Kent, JE Curran, TD Dyer, ...
European Psychiatry 36, 47-54, 2016
|Transcriptomics and the mechanisms of antidepressant efficacy|
K Hodgson, KE Tansey, TR Powell, G Coppola, R Uher, MZ Dernovšek, ...
European Neuropsychopharmacology 26 (1), 105-112, 2016
|Investigation of blood mRNA biomarkers for suicidality in an independent sample|
N Mullins, K Hodgson, KE Tansey, N Perroud, W Maier, O Mors, ...
Translational psychiatry 4 (10), e474, 2014
|The genome‐wide expression effects of escitalopram and its relationship to neurogenesis, hippocampal volume, and antidepressant response|
TR Powell, T Murphy, S de Jong, SH Lee, KE Tansey, K Hodgson, R Uher, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 174 …, 2017
|Inferring pathobiology from structural MRI in schizophrenia and bipolar disorder: Modeling head motion and neuroanatomical specificity|
N Yao, AM Winkler, J Barrett, GA Book, T Beetham, R Horseman, O Leach, ...
Human brain mapping 38 (8), 3757-3770, 2017
|Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response|
K Hodgson, SJ Mufti, R Uher, P McGuffin
Genome medicine 4 (6), 52, 2012
|Advancing psychiatric genetics through dissecting heterogeneity|
K Hodgson, P McGuffin, CM Lewis
Human Molecular Genetics 26 (R2), R160-R165, 2017
|Genetics of Depression|
K Hodgson, P McGuffin
|COMBINING CLINICAL AND GENETIC VARIABLES TO PREDICT ANTIDEPRESSANT TREATMENT RESPONSE: A MACHINE LEARNING APPROACH|
R Iniesta, K Hodgson, K Malki, W Maier, M Rietschel, O Mors, J Hauser, ...
EUROPEAN NEUROPSYCHOPHARMACOLOGY 27, S353-S354, 2017